Global Skin Excision Market, By Type (Electrosurgical Excision Devices, Laser Excision Devices, Blades and Scalpels, curettes and gouges, and Others), By Application (Skin Cancer Excision, Lesion Removal, Wound Debridement, Acne Scar Removal, and Others),

Global Skin Excision Market, By Type (Electrosurgical Excision Devices, Laser Excision Devices, Blades and Scalpels, curettes and gouges, and Others), By Application (Skin Cancer Excision, Lesion Removal, Wound Debridement, Acne Scar Removal, and Others), By Procedure Type (Brachioplasty, Mastopexy, Rhytidectomy, Panniculectomy, Thigh Lift, Tummy Tuck, Neck Lift, Brow Lift, Breast Reduction, and Others), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Global skin excision market was valued at US$ 29.9 Bn in 2023 and is expected to reach US$ 59.14 Bn by 2031, growing at a compound annual growth rate (CAGR) of 8.9% from 2024 to 2031.

Figure 1. Global Skin Excision Market Share (%), By Region, 2024

The skin excision market is well positioned for steady growth in the near future. The skin serves as the protective outer layer for the human body and skin excisions are procedures that involve surgically removing a patch of skin for diagnostic or therapeutic purposes. Common reasons for skin excisions include removing skin cancers, precancerous lesions, cysts, wounds, or scar tissue. Advancing technologies for minimal invasive techniques are improving patients' experience and outcomes for skin excision procedures. With rising skin cancer incidence rates globally due to environmental factors like increased ultraviolet (UV) exposure, the demand for skin excision surgeries is projected to increase substantially.

Market Dynamics:

Global skin excision market is driven by factors such as increasing incidence of skin cancers and other dermatological conditions globally. According to the World Health Organization (WHO), over 3 million new cases of non-melanoma skin cancers are diagnosed worldwide each year. Rising UV ray exposure due to ozone depletion and lifestyle changes is contributing to higher rates of skin cancers. Moreover, growing aging population prone to skin lesions is boosting the market growth. However, high cost of Mohs micrographic surgery and preference for non-surgical treatments in some cases are restricting the market expansion to some extent. On the flip side, ongoing surgical and technological advancements in minimally invasive excision techniques are creating new opportunities. Innovations improving efficacy, recovery time, and cosmetic outcomes are fueling adoption.

Public health campaigns and advancements in diagnostic techniques have led to earlier detection of skin cancers and pre-cancerous conditions, which often necessitate excision as part of the treatment. As the global population ages, the number of age-related dermatological conditions, including skin cancers, tends to increase due to cumulative sun exposure and other factors, thereby boosting the need for skin excision services. Increased exposure to ultraviolet (UV) radiation due to depleted ozone levels, tanning practices, and recreational sun exposure without adequate protection are contributing to the incidence of skin conditions requiring excision. Improvements in surgical techniques and the development of more precise and minimally invasive excision methods result in more effective and aesthetically favorable outcomes, thereby encouraging their adoption by dermatologists and patients.

For instance, on April 27, 2023, 3M, 3M veraflo therapy, with both 3M veraflo cleanse choice complete dressing and 3M V.A.C. veraflo cleanse choice dressing, received the U.S. Food and Drug Administration (FDA) clearance for hydro mechanical removal of infectious materials, non-viable tissue and wound debris which reduces the number of surgical debridements required, while promoting granulation tissue formation, thus creating an environment that promotes wound healing.

Key features of the study:

• This report provides in-depth analysis of the global skin excision market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2024–2031), considering 2023 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global skin excision market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Ethicon Inc, Richard Wolf GMBH, Becton, Dickinson and Company, Integra LifeSciences, Exsurco Medical, Limbs & Things LTD, KARL STORZ GmbH & Co. KG, Aesculap, Inc., Medtronic, Zimmer Biomet, B. Braun SE, Conmed Corporation, Symmetry Surgical Inc., and Surtex Instruments Limited.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global skin excision market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global skin excision market.

Detailed Segmentation:

• Global Skin Excision Market, By Type:
• Electrosurgical Excision Devices
• Laser Excision Devices
• Blades and Scalpels
• Curettes and Gouges
• Others
• Global Skin Excision Market, By Application:
• Skin Cancer Excision
• Lesion Removal
• Wound Debridement
• Acne Scar Removal
• Others
• Global Skin Excision Market, By Procedure Type:
• Brachioplasty
• Mastopexy
• Rhytidectomy
• Panniculectomy
• Thigh Lift
• Tummy Tuck
• Neck Lift
• Brow Lift
• Breast Reduction
• Others
• Global Skin Excision Market, By End User:
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Others
• Global Skin Excision Market, By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa
• Top Companies in Global Skin Excision Market:
• Ethicon Inc
• Richard Wolf GMBH
• Becton, Dickinson and Company
• Integra LifeSciences
• Exsurco Medical
• Limbs & Things LTD
• KARL STORZ GmbH & Co. KG
• Aesculap, Inc.
• Medtronic
• Zimmer Biomet
• Braun SE
• Conmed Corporation
• Symmetry Surgical Inc.
• Surtex Instruments Limited